These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12824204)

  • 1. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study.
    Austin PC; Mamdani MM; Tu K; Jaakkimainen L
    JAMA; 2003 Jun; 289(24):3241-2. PubMed ID: 12824204
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in practice since the publication in 2007 of further results from the Women's Health Initiative and the Million Women Study.
    Cust MP
    Menopause Int; 2007 Dec; 13(4):141-3. PubMed ID: 18088523
    [No Abstract]   [Full Text] [Related]  

  • 3. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy and vasomotor symptoms after the Women's Health Initiative.
    Crawford SL
    Menopause; 2014 May; 21(5):439-41. PubMed ID: 24667356
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative].
    Tuomikoski P; Lyytinen H; Korhonen P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O; Mikkola TS
    Duodecim; 2014; 130(21):2209. PubMed ID: 25582016
    [No Abstract]   [Full Text] [Related]  

  • 6. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the Women's Health Initiative trial on the practice of prophylactic oophorectomy and the prescription of estrogen therapy.
    Chan LY; Yuen PM
    Fertil Steril; 2004 Jun; 81(6):1699-700. PubMed ID: 15193501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the Women's Health Initiative study on incident clonidine use in Ontario, Canada.
    Austin PC; Mamdani MM; Tu K
    Can J Clin Pharmacol; 2004; 11(2):e191-4. PubMed ID: 15520472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
    Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
    J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 11. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Woman's Health Initiative and one of many unintended consequences.
    Simon JA
    Menopause; 2016 Oct; 23(10):1057-9. PubMed ID: 27623202
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
    Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
    Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormones down under: hormone therapy use after the Women's Health Initiative.
    Travers C; O'Neill SM; Khoo SK; King R
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):330-5. PubMed ID: 16866795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and benefits of hormone replacement therapy, revisited. An update on the Women's Health Initiative study, which in 2002 changed the landscape of hormone replacement therapy.
    Duke Med Health News; 2014 Jan; 20(1):5-6. PubMed ID: 25632509
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing use of hormone therapy among minority women since the Women's Health Initiative.
    Helenius IM; Korenstein D; Halm EA
    Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy: is it OK after all? Weighing symptom relief against the risk.
    Health After 50 Sci Am Consum Health; 2016; 27(14):3-5. PubMed ID: 27062750
    [No Abstract]   [Full Text] [Related]  

  • 20. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.